CALLIGARI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.797
AS - Asia 888
EU - Europa 529
SA - Sud America 113
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.356
Nazione #
US - Stati Uniti d'America 1.771
SG - Singapore 377
IT - Italia 249
CN - Cina 129
VN - Vietnam 126
HK - Hong Kong 117
RU - Federazione Russa 98
BR - Brasile 93
BD - Bangladesh 41
IE - Irlanda 37
JP - Giappone 34
GB - Regno Unito 30
DE - Germania 26
FI - Finlandia 17
CA - Canada 16
IN - India 16
FR - Francia 15
NL - Olanda 10
ID - Indonesia 9
PL - Polonia 9
KR - Corea 8
MA - Marocco 8
AT - Austria 5
ES - Italia 5
MX - Messico 5
ZA - Sudafrica 5
AR - Argentina 4
CH - Svizzera 4
PH - Filippine 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
SA - Arabia Saudita 3
SE - Svezia 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.356
Città #
Wilmington 387
Houston 328
Singapore 247
San Jose 118
Ashburn 116
Hong Kong 114
Rome 109
Fairfield 95
Beijing 55
Council Bluffs 45
Woodbridge 41
Cambridge 40
Ho Chi Minh City 39
Seattle 39
Santa Clara 36
Tokyo 33
Hanoi 32
Dublin 31
Los Angeles 30
New York 25
Medford 24
Creede 22
Dallas 15
Moscow 14
Ann Arbor 13
Lappeenranta 13
Nuremberg 13
The Dalles 13
Buffalo 12
Lawrence 12
Milan 11
São Paulo 11
Dearborn 10
Lauterbourg 10
London 10
Orem 9
Redondo Beach 9
Seoul 8
San Diego 7
Warsaw 7
Biên Hòa 6
Chandler 6
Chicago 6
Da Nang 6
Atlanta 5
City of London 5
Colorado Springs 5
Denver 5
Guangzhou 5
Hải Dương 5
Menlo Park 5
North Bergen 5
Bologna 4
Brooklyn 4
Bắc Ninh 4
Florence 4
Frankfurt am Main 4
Haiphong 4
Johannesburg 4
Le Polo 4
Montreal 4
Mountain View 4
Porto Alegre 4
Salvador 4
Segni 4
Shanghai 4
Toronto 4
Viterbo 4
Zurich 4
Belo Horizonte 3
Can Tho 3
Caraguatatuba 3
Casablanca 3
Engelhard 3
Helsinki 3
Hyderabad 3
Las Vegas 3
Phoenix 3
Pune 3
Redwood City 3
Reggio Emilia 3
San Francisco 3
Tashkent 3
Vienna 3
Washington 3
Almere Stad 2
Augusta 2
Bari 2
Basingstoke 2
Bracciano 2
Cairo 2
Casorate Primo 2
Chennai 2
Cincinnati 2
Del Norte 2
Dhaka 2
Dubai 2
Fortaleza 2
Guaíba 2
Hangzhou 2
Totale 2.413
Nome #
Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome 298
Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors 260
Nano-bio interactions: a neutrophil-centric view 240
Pathogenic PTPN11 variants involving the poly-glutamine Gln255-Gln256-Gln257 stretch highlight the relevance of helix B in SHP2's functional regulation 236
Design, synthesis, antibacterial potential, and structural characterization of N-acylated derivatives of the human autophagy 16 polypeptide 229
Molecular investigation of SARS-CoV-2 proteins and their interactions with antiviral drugs 188
Gating-affecting mutations in KCNK4 cause a recognizable neurodevelopmental syndrome 173
A Recurrent gain-of-function mutation in CLCN6, encoding the ClC-6 Cl−/H+-exchanger, causes early-onset neurodegeneration 155
Structural determinants of phosphopeptide binding to the N-terminal Src homology 2 domain of the SHP2 phosphatase 126
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state 110
Molecular and cellular evidence of a direct interaction between the TRAF2 C-terminal domain and ganglioside GM1 108
Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches 97
Targeting oncogenic Src homology 2 domain-containing phosphatase 2 (SHP2) by inhibiting its protein-protein interactions 93
Isoamphipathic antibacterial molecules regulating activity and toxicity through positional isomerism 92
Investigation of the Mechanism of Action of Natural and Synthetic Monoterpenoids: For a New Route in Antimycotic Molecules 91
Computational Evaluation of Peptide–Protein Binding Affinities: Application of Potential of Mean Force Calculations to SH2 Domains 90
Fluorescent Labeling Can Significantly Perturb Measured Binding Affinity and Selectivity of Peptide-Protein Interactions 90
Fluorescence Anisotropy and Polarization in the Characterization of Biomolecular Association Processes and Their Application to Study SH2 Domain Binding Affinity 80
Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome 74
Mechanistic Insights into the Membrane Permeabilization Activity of Antimicrobial Prenylated Isoflavonoids: A Comparative Study of Glabridin, Wighteone, and Lupiwighteone 72
Dominantly acting variants in ATP6V1C1 and ATP6V1B2 cause a multisystem phenotypic spectrum by altering lysosomal and/or autophagosome function 70
Modelling of Ca 2+ -promoted structural effects in wild type and post-translationally modified Connexin26 62
Insights into internal dynamics of 6-phosphogluconolactonase from Trypanosoma brucei studied by nuclear magnetic resonance and molecular dynamics 56
nMoldyn - Interfacing spectroscopic experiments, molecular dynamics simulations and models for time correlation functions 52
Adaptation of Extremophilic Proteins with Temperature and Pressure: Evidence from Initiation Factor 6 51
Decoding C-SH2 Domain/Peptide Interactions in SH2 Domain-Containing Tyrosine Phosphatase 2: A Molecular Framework for Rational Inhibitor Design 46
Integrated Computational Approach to the Electron Paramagnetic Resonance Characterization of Rigid 3(10)-Helical Peptides with TOAC Nitroxide Spin Labels 42
Decomposition of Proteins into Dynamic Units from Atomic Cross-Correlation Functions 40
Peptide inhibitors of proteinprotein interactions targeted to SRC homology 2 domains: a combined computational and spectroscopic design approach 34
Effects of peptide labeling on fluorescence binding assays to Src homology 2 domains: the case of protein-protein interactions inhibitors of the oncogenic phosphatase SHP2 34
Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor 33
Multiple scale dynamics in proteins probed at multiple time scales through fluctuations of NMR chemical shifts 28
A systematic framework for peptide-based inhibition of SHP2 protein-protein interactions 16
Allosteric activation in multi-domain proteins explored by multiscale simulations: The case of phosphatase SHP2 11
Decoupling SHP2 allosteric activation from binding to its phosphorylated partners 11
Exploring Protein Conformational Transitions in the Second Timescale through Multiscale Molecular Dynamics: The Case of SHP2 Activation 10
Inhibition of Protein-protein Interactions Involving Shp2: An Innovative Strategy Against Rtk-driven Cancers 8
Optimization of Peptide-based Inhibitors of Shp2 Oncogenic Protein: Towards Effective Drugs Against Rare Developmental Disorders and Juvenile Haematological Malignancies 7
Totale 3.513
Categoria #
all - tutte 12.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 14 16 8 4 6 1 23 11 13 17 25 29
2022/2023148 17 1 1 3 2 28 13 4 61 0 15 3
2023/2024124 6 1 12 8 20 10 12 2 7 25 2 19
2024/2025531 11 49 25 29 5 78 89 39 35 55 78 38
2025/20261.486 137 86 115 93 125 48 247 164 146 136 87 102
2026/202733 33 0 0 0 0 0 0 0 0 0 0 0
Totale 3.513